Southern Acids (M) Bhd (XKLS:5134) Cyclically Adjusted Revenue per Share: RM7.52 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5134 Southern Acids (M) Bhd XKLS:5134
69 GF Score
Price RM3.10
GF Value RM2.88
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Southern Acids (M) Bhd Cyclically Adjusted Revenue per Share?

Southern Acids (M) Bhd XKLS:5134 +1.31% 69 Cyclically Adjusted Revenue per Share is RM7.52 as of Mar. 2026. GuruFocus rates XKLS:5134 with a GF Score™ of 69/100 and a GF Value™ of RM2.88 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Southern Acids (M) Bhd's adjusted revenue per share for the three months ended in Mar. 2026 was RM1.474. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is RM7.52 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Southern Acids (M) Bhd's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Southern Acids (M) Bhd was 10.10% per year. The lowest was 5.90% per year. And the median was 8.35% per year.

As of today (2026-07-23), Southern Acids (M) Bhd's current stock price is RM3.10. Southern Acids (M) Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was RM7.52. Southern Acids (M) Bhd's Cyclically Adjusted PS Ratio of today is 0.41.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Southern Acids (M) Bhd was 0.81. The lowest was 0.40. And the median was 0.58.


Southern Acids (M) Bhd  (XKLS:5134) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Southern Acids (M) Bhd's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.10/7.52
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Southern Acids (M) Bhd was 0.81. The lowest was 0.40. And the median was 0.58.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Southern Acids (M) Bhd Cyclically Adjusted Revenue per Share Related Terms


Southern Acids (M) Bhd Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Southern Acids (M) Bhd's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Southern Acids (M) Bhd Cyclically Adjusted Revenue per Share Chart

Southern Acids (M) Bhd Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.78 6.33 6.69 7.12 7.52

Southern Acids (M) Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.12 7.23 7.33 7.36 7.52

XKLS:5134 vs HON, MMM: Cyclically Adjusted Revenue per Share Comparison

For the Conglomerates subindustry, Southern Acids (M) Bhd's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Southern Acids (M) Bhd Cyclically Adjusted PS Ratio vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Southern Acids (M) Bhd's Cyclically Adjusted PS Ratio falls into.


XKLS:5134
69GF Score
Southern Acids (M) Bhd XKLS:5134
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Southern Acids (M) Bhd Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Southern Acids (M) Bhd's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.474/330.2130*330.2130
=1.474

Current CPI (Mar. 2026) = 330.2130.

Southern Acids (M) Bhd Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.218 241.018 1.669
201609 1.178 241.428 1.611
201612 1.401 241.432 1.916
201703 1.640 243.801 2.221
201706 1.305 244.955 1.759
201709 1.381 246.819 1.848
201712 1.452 246.524 1.945
201803 1.466 249.554 1.940
201806 1.153 251.989 1.511
201809 1.118 252.439 1.462
201812 1.071 251.233 1.408
201903 1.068 254.202 1.387
201906 1.041 256.143 1.342
201909 1.218 256.759 1.566
201912 1.251 256.974 1.608
202003 1.355 258.115 1.733
202006 1.156 257.797 1.481
202009 1.276 260.280 1.619
202012 1.356 260.474 1.719
202103 1.660 264.877 2.069
202106 1.884 271.696 2.290
202109 1.802 274.310 2.169
202112 2.243 278.802 2.657
202203 2.695 287.504 3.095
202206 2.169 296.311 2.417
202209 2.045 296.808 2.275
202212 2.015 296.797 2.242
202303 1.804 301.836 1.974
202306 1.572 305.109 1.701
202309 1.698 307.789 1.822
202312 1.698 306.746 1.828
202403 1.662 312.332 1.757
202406 1.760 314.175 1.850
202409 2.177 315.301 2.280
202412 2.214 315.605 2.316
202503 1.813 319.799 1.872
202506 1.651 322.561 1.690
202509 1.863 324.800 1.894
202512 1.723 324.054 1.756
202603 1.474 330.213 1.474

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of RM7.52 mean?
Southern Acids (M) Bhd (XKLS:5134) has a Cyclically Adjusted Revenue per Share of RM7.52 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's Cyclically Adjusted Revenue per Share too high?
Southern Acids (M) Bhd's current Cyclically Adjusted Revenue per Share is RM7.52. Overall, Southern Acids (M) Bhd has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Cyclically Adjusted Revenue per Share compare to HON and MMM?
Southern Acids (M) Bhd's Cyclically Adjusted Revenue per Share of RM7.52 can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Conglomerates company?
A good Cyclically Adjusted Revenue per Share depends on the Conglomerates industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current Cyclically Adjusted Revenue per Share is RM7.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.10 — trading 7.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is RM7.52. Southern Acids (M) Bhd's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Cyclically Adjusted Revenue per Share is RM7.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?

Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued. The current stock price of RM3.10 is trading 7.6% above its estimated GF Value™ of RM2.88. GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.

Key valuation signals for XKLS:5134:

  • Cyclically Adjusted Revenue per Share: RM7.52
  • GF Value™: RM2.88 vs. price of RM3.10 (7.6% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Southern Acids (M) Bhd Business Description

Address No. 8, Jalan Batu Tiga Lama, Level 29, Centro Tower, Klang, SGR, MYS, 41300
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
69GF Score

Get the complete analysis for XKLS:5134

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.10
Price
RM2.88
GF Value